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Characterisation of protective helminth acquired immunity in humans or experimental models has focused
on effector responses with little work conducted onmemory responses. Here we show for the first time, that
human helminth infection is associated with altered proportions of the CD41 memory T cells, with an
associated alteration of TH1 responses. The reduced CD41memory T cell proportions are associated with a
significantly lower ratio of schistosome-specific IgE/IgG4 (marker for resistance to infection/re-infection)
in uninfected older people. Helminth infection does not affect the CD81memory T cell pool. Furthermore,
we show for the first time in a helminth infection that the CD41 memory T cell proportions decline
following curative anti-helminthic treatment despite increased CD41 memory cell replication. Reduced
accumulation of the CD41 memory T cells in schistosome-infected people has implications for the
development of natural or vaccine induced schistosome-specific protective immunity as well as for
unrelated pathogens.
T
he adaptive immune system, largely orchestrated by lymphocytes, is central to the development of acquired
immunity against current and subsequent infection with pathogens. T lymphocytes are key regulators and
effectors of the adaptive immune responses. Upon contact with specific antigen (through natural infection
or vaccination), they differentiate and expand into two populations, effector and memory cells. The generation
and persistence of the latter provides the basis for an efficient immune response in subsequent encounters with
the pathogen preventing or reducing re-infection.
CD41 T cells are central in the development of protection against re-infection with human helminth parasites
including schistosomes (see review1). To date, helminth vaccine development has focused on inducing CD41
effector responses directed against the parasites with little understanding of the dynamics of CD41 memory
responses2–4. Compared to CD81 memory relatively less is known about the development of CD41 memory T
cells during human infections. Furthermore, even less is known about the development of CD41memory during
chronic antigen stimulation from parasites as occurs in the presence of schistosome eggs trapped in the liver, or
during repeated re-infection events as occurs in populations endemically exposed to helminth infections. These
features of helminth infections are likely to influence the development of naturally acquired immunity as well as
the efficacy and immunopathological consequences of helminth vaccines, for example vaccinating people already
exposed to the parasite may result in pathology as reported from a trial of a human hookworm vaccine candidate5.
Understanding the interaction between helminth infection and the overall host immune responses is important
for optimising vaccination against schistosomes as well as unrelated parasites. There is a growing body of
literature indicating that helminths can modulate the adaptive immune responses directed against themselves
as well as immune responses directed against unrelated, so called bystander antigens6,7. Furthermore, descriptive
studies in humans have shown that vaccine efficacy is reduced in helminth infected individuals a phenomenon
that has largely been attributed to the development of regulatory responses (reviewed in8), but may also be related
to failure to optimally developmemory responses. To date, there have been few studies on the interaction between
helminth parasites and the development of memory T cell responses in people exposed to/infected with helminth
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parasites. Recently a study in a small group of 29 people exposed to
the nematode parasiteWuchereria bancrofti, which causes lympatic
filariasis, suggested that alteration of memory T cell responses may
be involved in the immunomodulation ofmemory T cell responses in
individuals with patent infection9.
Therefore, we set out to determine whether infection with a hel-
minth parasite is associated with changes in the memory T cell pool
in humans and also determine to what extent the function of effector
cells would be altered. The study focused on people naturally exposed
to the parasite Schistosoma haematobium, commonly known as the
blood fluke. Populations resident in areas endemic for schistoso-
miasis show a characteristic age-infection profile with infection
intensity rising early during childhood, peaking around 9–14 years
and then declining in adulthood10 a pattern largely attributed to the
development of acquired immunity as a result of cumulative expo-
sure to parasite antigens11,12.
The processes and drivers of the generation, differentiation and
persistence of memory T lymphocytes in humans are less well char-
acterised relative to the mouse model13. Nonetheless, several key
features of human memory T lymphocytes have been described.
CD41 memory and CD81 memory T cell accumulate with host
age relative to naı¨ve T cells14,15 due to reduced thymic output of
naı¨ve T cells and accumulation of memory T cells in response to
constant exposure to pathogenic and environmental antigens16.
CD81 memory cell differentiation and homeostasis is relatively well
understood17,18, whereas the mechanisms of CD41 memory T cell
generation and persistence are still being debated13,19,20. Since the
mechanisms of CD41 memory T cell generation are less well
described, it is not predictable whether helminths are potentially able
tomodulate this generation. Therefore, the first aim of this study was
to determine if the age-related accumulation of memory T cells dif-
fers in people infected with helminths compared to uninfected peo-
ple. The second aim of the study was to determine the effects of
curative anti-helminthic treatment on the memory T cell pool, since
curative anti-helmintic treatment results in both increased reactivity
against helminth antigens and possible improved vaccine efficacy in
helminth endemic areas8,21,22. Mechanistic studies of how anti-hel-
minthic treatment may mediate this remain unexplored and may
include alterations in T cell memory proportions.
Results
Helminth epidemiology in study population. Since this study
focused on S. haematobium an area with low prevalences of S.
mansoni and soil-transmitted helminths (STH) was selected for the
study based on previous National Schistosomiasis surveys23 and pre-
surveys showing a low prevalence of S. mansoni (,2%) and the
absence of STH. Only lifelong residents, and thus people exposed
to schistosomiasis throughout their life by frequent contact to
infective water as assessed by questionnaire (allowing age to be
used as a proxy for their cumulative history of exposure to
schistosomiasis)24, but who had never received anti-helminthic
treatment were enrolled in the study. Therefore, egg negative
young children are yet to be infected while egg negative old people
have developed resistance to infection/re-infection. All participants
were negative for HIV and Plasmodium infection.
105 participants (schistosome infection prevalence 5 61.0% and
mean infection intensity 5 38.9 eggs per 10 ml urine (SEM58.5,
range 0–571.0) were enrolled in the study. Partitioning the partici-
pants by age as is routine24,25, showed that infection levels follow the
typical age-infection profile for schistosome infections in high trans-
mission areas of rising and peaking in childhood and declining
rapidly thereafter26. In this population infection levels are high in
the three youngest age groups (aged 6–17 years) (details in Table 1
and Supplementary Figure 1), but decline significantly in people aged
18 and above.
CD41 but not CD81memory T cells differ between infected and
uninfected older individuals. Proportions of total CD41 or CD81
T cells within CD31 T cells or lymphocytes did not differed between
uninfected and infected people in any of the four age groups
(Supplementary Figure 2).
The CD31 T cell compartment was divided into CD41 and
CD81 T cells and naı¨ve and memory T cells in these subsets were
differentiated using CD45RA as a marker and quantified. As
depicted in Figure 1a, there were significantly higher proportions
of CD41 memory T cells in uninfected compared to infected indi-
viduals. No significant differences were observed in CD81 memory
T cell proportions (Figure 1b). Further statistical analysis showed
that age, but not sex had a significant influence on CD41 memory
T cell proportions whereas CD81 memory T cells were not affected
by either of these variables (Table 2).
LowCD41memory T cell proportions are associatedwith current
infection. In order to determine if the differences in CD41 memory
T cells was due to current infection or the history of infection,
serological levels of whole worm homogenate (WWH)-specific
IgM, an indicator of current exposure to parasite antigens and IgE,
an indicator of memory responses to parasite antigens were
compared between the schistosome-infected and uninfected par-
ticipants. The ratio of IgM to IgE as an indicator of the relative
contribution was negatively correlated to CD41 memory T cell
(r 5 20.246, p 5 0.032) meaning that lower CD41 memory T
cells are associated with higher worm-specific IgM and/or lower IgE,
and are thus associated with current rather than previous infection.
Furthermore it could be that individuals with lower proportions of
CD41 memory T cells are more likely to be infected and therefore
lowCD41memory T cells are the cause rather than the consequence
Table 1 | Study population
S. haematobium
Age group N mean age in years (range) Male/female Prevalence in % (95% CI) Mean egg count 6 SEM (range)
total 105 16.2
(6–84)
43/62 61.0
(52.1–69.9)
38.9 6 8.5
(0 –571)
6 – 9 years 32 7.6
(6–9)
16/16 68.8
(52.9–84.7)
44.6 6 19.3
(0 – 571)
10 – 12 years 30 11.1
(10–11)
17/13 76.7
(61.7–91.7)
50.7 6 15.5
(0 – 450)
13 – 17 years 30 22.6
(13–84)
7/23 56.7
(39.2–74.2)
38.0 6 14.8
(0 – 403)
181 years 13 51.8
(18–84)
3/10 15.4
(0–34.9)
0.18 6 0.13
(0 – 1.3)
SEM – Standard error of mean, CI – Confidence interval.
www.nature.com/scientificreports
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of an infection. To address this hypothesis we selected individuals
who were not infected at baseline. Infection levels of the same indi-
viduals were again assessed 18 month later to determine if those
individuals were infected within this period. Subsequently propor-
tions of CD45RA-CD41 T cells were compared between people
who remained uninfected within this period and became infected
(Supplementary Figure 3). We did not observe difference in CD41
memory T cell proportion between those two groups indicating that
low levels of CD41 memory T cells are correlated to higher suscept-
ibility to infection.
The rate of which CD41memory T cell accumulate with age differs
between schistosome infected and uninfected individuals. The
differences in CD41 T cell proportions in schistosome infected
Figure 1 | CD41 and CD81memory T cells in S. haematobium infections. PBMC were gated on CD31CD41 (a) or CD31CD81 (b) positive cells
and analysed for the proportions of memory cells by gating on CD45RA- cells. Proportions are expressed as percentages of total CD41 or CD81 cells
respectively. Data were subsequently grouped in uninfected and infected people. Means are shown as gray line and ranked data are compared by a
non-parametric Mann-Whitney-U test. CD31CD41CD45RA- T cells were further divided into CD31CD45RA-CD62L- TEM (c) and
CD31CD45RA-CD62L1 TCM (d) and compared between uninfected and infected individuals. Means are shown as gray line and compared by a non-
parametric Mann-Whitney-U test.
Table 2 | Effects of sex, age group and infection status on CD41 and CD81 memory T cells
Dependent variable Explanatory variable df F – value p – value
CD41 memory T cells sex 1, 104 2.649 0.062
age group 2, 104 30.313 , 0.001
infection status 1, 104 2.762 0.100
age group * infection status 3, 104 3.304 0.024
CD81 memory T cells sex 1, 95 0.304 0.583
age group 3, 95 1.385 0.161
infection status 1, 95 0.130 0.720
age group * infection status 3, 95 0.494 0.910
Results from univariate analyses of variance are shown determining the effect of host sex, age group and infection status and the interaction of age group and infection status. Variables with significant
influence are highlighted in bold. df – degree of freedom.
www.nature.com/scientificreports
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versus uninfected people differed with host age (Table 2). To further
dissect how the relationship between CD41 memory T cells and
infection status varied with age, the data were divided into four age
groups and uninfected were compared to infected individuals
(Figure 2a). Whereas in the two younger age groups the proportions
of CD41 memory T cells are similar between uninfected and infected
individuals, in the third age group (13–17 years) there are significantly
lower CD41 memory T cells. In the oldest age group (181 years),
there are fewer CD41 memory T cells in infected versus uninfected
people but this difference was not statistically significant. This pattern
was not observed for CD81 memory T cells (Figure 2b).
To determine the dynamics of the age-related changes in CD41
memory T cell proportions, data were divided by infection status and
the correlation coefficients between CD41 T cell proportions and
age (continuous across age groups) compared (Table 3). In both
uninfected and infected individuals CD41 memory T cells rose sig-
nificantly with age, but the rate of this increase was higher in the
uninfected group compared to the infected group with significant
differences in the correlation coefficients as assessed by analysis of
homogeneity (Table 3).
To gain insight in potential mechanism responsible for altered
proportions of CD41 memory T cells expression levels of IL-7Ra
Figure 2 | Proportions of CD41 and CD81 memory T cells in different age groups. CD31CD41CD45RA- (a), CD31CD81CD45RA- (b),
CD31CD45RA-CD62L- TEM (c) and CD31CD45RA-CD62L1 TCM (d) populations were further divided into four age groups. Means 6 SEM are
presented and infected (dashed lines) versus uninfected (solid lines) were compared. Differences between infected and uninfected were tested by ANOVA.
Table 3 | Correlation analysis between age and different memory T cell subsets
T cell subset population
correlation to age r to z transformation
r - value p - value z - value p - value
CD41 memory T cells total population 0.606 , 0.001
uninfected 0.654 , 0.001 2.660 0.004
infected 0.318 0.005
CD81 memory T cells total population 0.192 0.031
uninfected 0.116 0.138 20.159 0.060
infected 0.337 0.006
CD41 central memory T cells total population 0.433 , 0.001
uninfected 0.599 , 0.001 3.640 , 0.001
infected 0.177 0.087
CD41 effector memory T cells total population 0.435 , 0.001
uninfected 0.573 0.001 3.210 , 0.001
infected 0.197 0.065
A Pearson correlation analysis was performed between age (continuous across age groups) and the different memory T cell subsets (after controlling for the effect of sex) for either the total population or
divided in uninfected and infected groups. r and p – values are given. Subsequently the correlation coefficients of the infected versus uninfected groups were compared by r to z transformation and the
associated z - values and p - values are indicated. Significant values (p , 0.05) are indicated in bold.
www.nature.com/scientificreports
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on CD45RA- memory T cells were analysed. As indicated in
Supplementary Figure 4. No differences between uninfected and
infected individuals in any of the four age groups was observed. In
addition we analysed expression levels of the inhibitory receptor
CTLA-4/CD152. These data were only available on a subset of sam-
ples (N 5 51, aged 6–17 years). As shown in Figure 3a in infected
individuals proportions of CTLA-41CD41 T cells significantly
increased with age (b 5 0.473, p 5 0.005). This correlation with
age was not observed in uninfected people (b 5 0.119, p 5 0.662).
Proportions of CTLA-41 CD41 T cells differ between uninfected
and infected people in the age groups ranging from 10–17 years.
The rate of development of both the TEM and TCMCD41memory
T cell compartments differs between schistosome infected versus
uninfected individuals.CD41CD45RA-memory T cells were further
subdivided in central memory (TCM) and effector memory (TEM)
subpopulations based on their expression of the CD62 Ligand
(CD62L) with TCM being CD62L1 and TEM being CD62L-. TEM
cells accounted for the majority of CD41 memory T cells (mean of
71.8%61.4% CD62L-CD45RA- of CD45RA-CD41 T cells) and
showed a similar pattern to total CD41 memory T cells. Schi-
stosome-infected individuals showed lower TEM than uninfected
people (Figure 1c) and after partitioning the population into age
groups, TEM cell proportions followed the same profile (Figure 2c). A
correlation analysis between age and proportions of CD41 memory T
cells was performed (Table 3). TEM increases with age in both infected
and uninfected individuals, but the correlation coefficient differs
significantly between both infected and uninfected groups indicating
a delayed development of TEM. In addition a subset of samples has
been analysed for TEM and TCM using CCR7, an alternative marker
to differentiate between CD41 TEM and TCM. Proportions of
TEM defined by either CCR7 or CD62L correlate to each other (p 5
0.001). The age-infection the age-infection pattern obtained CD45RA-
CCR7- or CD62L- CD41 memory T cells are comparable.
The proportions of TCM do not significantly differ between
infected and uninfected people (Figure 1d). Correlation analysis
revealed that there is a positive association between age and TCM
in uninfected individuals, but none in infected individuals. In
infected individuals TCM rather peak at the age of 10–12 years decline
again and subsequently increase in the oldest age group (Figure 2d).
Curative anti-helminthic treatment results in a reduction of
CD41 memory T cell proportion. In a next step we assessed if
treatment with the anti-helmintic drug praziquantel affects the
proportions of CD41 memory T cells. This would be particularly
informative since the analysis above indicated that current exposure
to schistosome infection as measured by IgM was associated with
lower levels of CD41 memory T cells. Proportions of CD41
memory T cells were compared pre- and six weeks post-treatment.
Following inclusion criteria detailed in the methods section, a total of
50 people were enrolled in the cohort study with 36 treated people
and 14 untreated people who formed the control group. As indicated
in Figure 4a no significant change was observed in the proportions of
total CD41 memory T cells in untreated individuals between the two
time points. However in treated individuals the proportions of CD41
memory T cells decreased significantly (Figure 4b) (p 5 0.015). No
significant changes occurred in CD81 memory T cell proportions in
either of the treated or untreated groups (Figure 4c, d).
The post-treatment decrease in CD41memory T cell proportions
is associated with increased proliferation of CD41 memory T
cells. To determine possible reasons for the decrease in CD41
memory T cells in treated people, we analysed the proportions of
CD311CD41 T cells. CD311CD41 T cells have been recently
shown to be a marker of recent thymic emigrants and CD31 is
mainly expressed on naı¨ve CD45RA1CD41 T cells27,28. There-
fore an increase of CD311CD41 T cells would indicate changes in
thymic output of naı¨ve CD41 T cells. However, as indicated in
Figure 5a and b, there was no significant change pre- and six weeks
post treatment in proportions of CD311CD41 T cells. Next we
analysed if there was a change in the replicative history of CD41
memory T cells by analysis of their telomere length. CD41
CD45RO1 memory T cells were purified using magnetic beads and
subsequently genomic DNA was isolated. Finally the relative length of
telomeres was analysed by quantitative PCR. We found an increase in
telomere length on CD41 memory T cells in the untreated group
indicating newly generated CD41 memory T cells within the six
week period (Figure 5c).
In contrast, in treated individuals telomere lengthwas significantly
reduced in CD41 memory T cells six weeks after treatment
Figure 3 | Uninfected older individuals have increased WWH-specific IgE/IgG4 ratios indicating the development of resistance and show differences
in their CTLA-41CD41 T cells. The proportions of CTLA-41CD41 T cells (a) and the ratio of whole worm homogenateWWH-specific IgE/IgG4 (b)
were determined, data divided into age groups and the difference between uninfected (solid lines) and infected (dashed lines) was analysed. Data are
derived from a subset of the total cohort (N 5 51, aged range 5–17 years), of which those data are available.
www.nature.com/scientificreports
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(Figure 5d) suggesting that those CD41 memory T cells underwent
more proliferation cycles following treatment.
The S. haematobiummean infection intensity in analyzed untreated
people increased from 77.5 (SEM518.7) to 111.0 eggs/10 ml urine
(SEM547.0), whereas the infection intensity of treated people
decreased from 100.2 (SEM539.3) to 0.023 eggs/10 ml urine with
only one individual having infection not cleared. We therefore
hypothesized that the changes in telomere length might be related
to changes in the infection intensity in a combined analysis of both
treated and untreated individuals. As shown in Supplementary Figure
5 the difference in infection intensity and the difference in telomere
length were significantly correlated to each other.
Functional impairment of CD41 memory T cells. Next the
relationship between the number of CD41 memory T cells and
their potential to produce IFN-c (as marker of TH1 effector
function) in a non-specific manner was analysed. PBMC were
stimulated with the mitogen phytohaemagglutinin PHA for 48
hours and supernatants analysed for the production of cytokines.
IFN-c production was significantly associated with CD41 memory
T cells proportions in uninfected individuals unlike in infected
individuals where there was no significant correlation between the
proportion of CD41 memory T cell proportions and IFN-c
production (Table 4). In contrast, neither of the two TH2 associated
cytokines (IL-4 and IL-5) correlated with the proportions of CD41
memory T cell in infected or infected individuals after statistically
controlling for the effects of sex and age. The activation status of
effector/memory CD41 T cells was assessed by determining the
proportion of HLA-DR1CD41 T cells. In uninfected individuals
CD41 memory T cells were positively associated with HLA-
DR1CD41 cells after allowing for the effects of sex and age
(Table 4). In contrast, there was no significant association between
CD41 memory T cells and HLA-DR1CD41 T cells in infected
people.
Schistosome-specific responses in uninfected versus infected
people. To analyse if parasite specific cellular cytokine responses
are altered in people infected with S. haematobium we analysed
cytokine production by WWH-stimulated PBMC. The TH2
cytokine IL-4 did not differ between infected and uninfected and
infected individuals in any of the analysed age groups (data not
shown). Parasite-specific IFN-c was slightly higher in uninfected
individuals (mean 15.4 pg/ml 6 SEM 3.9) compared to uninfected
(mean 11.8 pg/ml 6 SEM 2.7) with the difference being most
pronounced in the age group of 10–12 years. However the
interaction between age group and infection status was statistically
not significant. In addition none of these parasite specific cytokines
show a correlation to proportions of CD41 memory T cells.
In addition to the cytokine responses, we also measured levels of
the schistosome-specific IgE and IgG4 directed against the adult stage
of the parasite which have been experimentally shown to be assoc-
iated with resistance and susceptibility to infection respectively29. We
Figure 4 | Effect of anti-helminthic treatment on CD41 and CD81 memory T cells. CD31CD41CD45RA- memory T cells (a, b) and
CD31CD81CD45RA- memory T cells (c, d) were quantified in either untreated controls (a, c) (N 5 14) or in individuals who received praziquantel
(b, d) (N536) at baseline and six weeks later. P – values obtained from a Wilcoxon paired sample test.
www.nature.com/scientificreports
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used the ratio of IgE/IgG4, an accepted marker of resistance to infec-
tion/re-infection30–32, to analyze the schistosome-specific memory
response. In younger individual no difference in the WWH-specific
IgE/IgG4 ratio was observed in infected versus uninfected people
(Figure 3b). However, older uninfected individuals (who have been
exposed to schistosome infections earlier in life) had a higher WWH-
specific IgE to IgG4 ratio (F2,49 5 6.043, p 5 0.018) consistent with
the development of resistance to schistosome infection.
Discussion
Helminth infections are chronic in nature providing constant anti-
genic stimulation for prolonged periods of time. In addition people
resident in helminth endemic areas experience multiple infection
events before the expression of protective acquired immunity. The
effect of these two features on the nature, development and main-
tenance of memory responses remains largely unknown. These basic
characteristics of helminth immune responses influence the develop-
ment of protective acquired immunity making their understanding a
critical step in harnessing the development of much needed vaccines
against human helminth infections4. Furthermore, gradually accu-
mulating evidence suggests that helminth infections can reduce the
efficacy of vaccines against unrelated pathogens through immuno-
logical mechanisms warranting an urgent understanding of the
development of both effector andmemory responses against schisto-
somes and other pathogens in people exposed to persistent and
repeated helminth infections. During persistent antigenic stimu-
lation, down-regulation of effector T-cell mediated33,34 and antibody
responses35 as a result of immune exhaustion has been described.
However, these studies have focused on CD81 T cells with relatively
less work conducted on CD41 T cells35,36. An experimental study in
Plasmodium has suggested that in contrast to the results in models
for CD81 T cells, continuous exposure to parasite antigens is
required for the maintenance of CD41 T cell-mediated immuno-
logical protection against the parasite37. Our studies and those of
Figure 5 | Effect of anti-helminthic treatment on CD311CD41 T cells and telomere length of CD41 memory T cells. CD41CD311 T cells were
quantified in PBMC samples either obtained from untreated controls (a) or individuals treated with praziquantel (b) at baseline and six weeks later.
CD41CD45RO1memory T cells were isolated from PBMC obtained from either untreated controls (N511) (c) or praziquantel treated people (N515)
(d) using magnetic beads. DNA was isolated and telomere length quantified using qPCR. Presented data are normalized to a single copy gene (36b4).
Table 4 | Correlation analysis between CD45RA-CD41 memory T
cells and PHA induced cytokine production HLA-DR1CD41 T cells
as marker of activation
Activation
uninfected infected
r-values p-values r-value p-values
HLA-DR1CD41 0.446 0.013 0.234 0.098
IFN-c 0.434 0.041 0.174 0.225
IL-4 0.387 0.062 0.102 0.329
IL-5 0.055 0.418 0.119 0.304
Correlation analysis was performed by partial correlation controlling for the effects of sex and age.
Significant correlations (p , 0.005) are indicated in bold.
www.nature.com/scientificreports
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others have shown that acquired immunity associated with protec-
tion against schistosome infection requires a threshold of antigen to
develop and that the slow development of acquired resistance to
schistosome infection reflects the time it takes to accumulate this
antigen38. Moreover, repeated exposures to parasite antigens follow-
ing anti-helminthic treatment result in the development of resistance
against re-infection39. Yet how these different features of helminth
infection affect the development of the T cell memory compartment
of the immune system has not been previously studied in human
populations.
To our knowledge, this makes this present study the first cohort
study which documents the dynamics of effector/memory T cell
proportions in a population exposed to a helminth infection. Our
study focused on people who had been exposed to schistosome infec-
tion throughout their lives so that their age was a proxy for their
cummulative history of schistosome infection. Overall the propor-
tion of CD41 memory T cells was significantly higher in uninfected
people compared to infected people. The uninfected group constitu-
tes a heterogenous group in terms of their history of schistososme
infection. Uninfected young people represent people who have yet to
be infected, while uninfected older people represent people who have
cleared infection encounted earlier in life and are currently resistant
to re-infection despite continued exposure to infective water24. The
study showed that independent of schistosome infection, the pro-
portion of CD41 and CD81 memory T cells increased with age as
has been reported for other human populations14,15. However, the
proportion of CD41 memory T cells but not CD81 memory T cells
differed significantly in people currently infected with schistosomes
compared to uninfected people, resulting in delayed accumulation of
CD41 memory T cells in the schistosome infected people. Despite
starting at similar levels, the increase of CD41 memory T cell popu-
lations with age in infected people is delayed compared to uninfected
people. Protective acquired immunity against schistosomes develops
with age and the rate at which this occurs is determined by the
intensity of infection12,24. The age group with the highest proportion
of memory CD41 T cells are uninfected adults who also had the
highest levels of schistosome specific IgE which is associated with
resistance to re-infection. CD41memory T cells have been shown to
mediate protection against re-infection in experiemental helminth
infection40 and the age-related pattern in CD41 memory T cells in
this population suggests that this population of cells is involved in the
development of protective immunity against the parasites.
To assess the relative contribution of a current versus a pre-
vious infection to the proportions of CD41 memory T cells, the
levels of adult worm-specific IgM and IgE were determined. IgM
reflects levels of current exposure to parsite antigens while IgE
reflects the development of protective immunity which develops
following cummulative exposure to parasite antigens giving an
indication of previous exposure to parasite antigens. Thus, the
ratio between the two provides a measure or current versus pre-
vious exposure to parasite antigens. The negative association
between the worm-specific IgM/IgE ratio and the CD41 memory
T cell proportions suggests that current infection rather than
history of infection is associated with reduced CD41 memory
T cell proportions.
In this population, TEM proportions were higher than TCM which
is contrary to published data for European donors41, but comparable
to the proportions reported in Malawians and Brazilians42,43 both
countries where schistosome infections are endemic44. The propor-
tions of TEM cells which mediate migration to peripheral tissue was
significantly lower in schistosome infected versus uninfected people.
This was not the case for TCM cells. TEM express a repertoire of
receptors which mediate migration to peripheral tissue. In older
individuals chronic schistosome infection is often associated with
severe immuno-pathology45 caused by effector/memory CD41 T
cells. Therefore, it is possible that the lower levels of TEM cells in
schistosome infected people might be due to enhanced migration to
the site of infection. However, in our study, the CD41T cellmemory
pool is altered rather than only the parasite-specific memory T cells.
That would mean that the migration would mean that the migration
capacity of CD41 memory T cells with different specifities might be
altered even under steady state conditions without other present
infections. This possibility needs further evaluation.
Furthermore we analyzed the expression of the inhibitory receptor
CTLA-4/CD152 which can limit proliferation of T cells46 and been
suggested to play a role in experimental filarial infection47. We could
show that the proportions of CTLA-41 T cells are higher in the age
groups from 10–17 years of age providing a potential mechanism of
limiting CD41 memory T cells over time. The difference in CTLA-41
T cells was already observed in the 10–12 years old individuals suggest-
ing that it needs some time until the inhibitory effect of CTLA-4 to be
reflected in CD41 memory T cells proportions. Although CTLA-4 is
expressed on regultory T cells it has also been suggested that CTLA-4
plays crucial role on CD41Foxp3- T cells47.
In uninfected people, both TCM and TEM proportions increase
with host age. In schistosome infected people, TEM also increase with
age albeit at lower levels than in uninfected people, but the TCM
peaked in the age group of 10–12 years. The TEM cell pool may be
reflecting the development of protective immune responses, while
the TCM pool may be reflecting exposure to the parasite antigens as
has been reported for IgE and IgM responses against schistoso-
miasis24,39. Thus, it seems the combination of lower TEM and different
TCM -age profile results in the differences observed in the CD41
memory T cell pool in schistosome infected versus uninfected parti-
cipants in the two older age groups. This contrasts with the results
reported from a study in filarial-infected patients, which showed a
reduced TCM compartment, but tended to have more TEM9. Possible
explanations for the discrepancy between the two studies are differ-
ences in antigen concentrations in the blood and differences related
to the parasites, since it has been suggested that antigen load can
influence TEM and TCM proportions48,49 and immune responses
between nematodes and trematodes differ1.
One possible explanation for the differences in the proportions
and dynamics of CD41 memory T cells in schistosome-infected
versus uninfected participants may be the differences in antigen pre-
sentation. CD41 effector and memory T cells require more substan-
tial presentation of antigens by antigen presenting cells than CD81
memory T cells50. In this population, we observed age-related differ-
ences in the proportion of plasmacytoid andmyeloid DCs in schisto-
some-infected versus uninfected people (Nausch et al submitted)
which is consistent with results published by other groups where
schistosome-infected people had reduced levels of HLA-DR, leading
to reduced T cells activation51. Another reason might be a regulation
of IL-7Ra on CD41 memory T cells, however levels of IL-7Ra did
not differ in our study.
Curative anti-helminthic treatment of schistosome infected peo-
ple results in both the reversal of schistosome-related immuno-
modulation52 and improved efficacy of vaccines as shown for a mal-
aria vaccine in an experimental model53, but mechanistic explana-
tions for these observations have yet to be fully explained. In this
study curative anti-helminthic treatment resulted in a significant
decline in the proportion of CD41 memory T cells which was not
observed in untreated indviduals. There was no increased output of
naı¨ve T cells in these treated individuals as determined by propor-
tions of CD311CD41 T cells27,28. Therefore, a possible explanation
for the decrease in the CD41 memory T cells post-treatment is that
the increased proliferation of these cells (indicated by reduced tele-
more lengths) following the increased antigenic stimulation from
antigens released by dying worms/removal of immunosuppression,
is subsequently followed by self limitation54 and therefore reduced
proportions of CD41 memory T cells. This activation may not be
limited to schistosome-specific CD41 memory T cells, but may also
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 472 | DOI: 10.1038/srep00472 8
lead to an activation/proliferation of CD41 memory T cells with
different specifities to other antigens55. Such an increase of non-
specific proliferation following treatment has been reported before56.
The fact that the telomere length in treated people did not increased
indicates that reactivation of already exisiting, but inhibited CD41
memory T cells contribute to an enhanced proliferation and contra-
dicts the hypothesis that newly generated CD41 effector/memory T
cells contribute to it.
The telomere length of the CD41memory T cell pool increased in
untreated people. Increased telomere length in CD41 memory T
cells might indicate enhanced generation of memory T cells from
naı¨ve cells. We could show that changes in infection intensity were
associated with changes in telomere length. Therefore increased tel-
omere length in CD41 memory T cells in untreated individuals
might be associated with the observed increase in S. haematobium
infection intensity.
Changes in infection intensity would correlate whith changes in
levels of antigens present. A recent experimenatal study has shown
that chronic/repeated exposure is required to maintain effective
CD41 effector/memory T cells in malaria and treatment changes
their proportions37.
The study also showed that the functional activity of the CD41
memory T cellsmeasured as the potential of the cells to produce IFN-
c was impaired in schistosome infected individuals compared to
uninfected individuals an effect which was not observed for TH2
cytokines. The strongmodulation of activatedCD41memory T cells
was supported by the fact that HLA-DR1CD41 were positively
associated with CD41 memory T cells in uninfected people, but
not in infected individuals.
The functional relevance of the higher CD41 memory T cells as
well asmechanism involved in the expression of protective immunity
against schistosome infection still require investigation. In this study
we demonstrated that the ratio of antibody responses shown to
mediate protection and susceptibility to infection (IgE and IgG4
respectively) which is a marker for resistance against infection i.e.
the IgE/IgG4 ratio, was significantly higher in egg negative older
people coinciding with the highest levels of CD41 memory T cells.
However, similar to previous studies by both ourselves and others,
there was no significant relationship between schistosome-specific
cytokine responses and infection status.
Taken together this study shows that infection with the helminth
parasite S. haematobium is associated with a non-specific modulation
of the CD41 effector/memory T cell pool but not CD81 cell pool.
This results in a delay in the accumulation of CD41 memory T cells
and is accompanied with alteration of TH1 type responses. The
mechanisms of this modulation remain to be investigated, but changes
in antigen-presenting cell populations present a possible explanation.
Anti-helmintic treatment results in changes in the proliferation of the
CD41 memory T cells and an associated decline in the proportion of
CD41 memory T cells. These results are important for improving our
understanding of the development of helminth-specific responses with
age, knowledge which can be harnessed for the development of vac-
cines against these important human and veterinary parasites.
Furthermore, since these effects are not restricted to schistosome-spe-
cific responses, the reduced memory T cell populations in schistosome
infected people have the potential to influence the efficacy of unrelated
vaccines and the aetiology/progression of immune disorders that are
mediated by CD41 responses. Further mechanistic studies in experi-
mental models complemented by human studies will clarify the role of
memory T cells in the development of protective immunity against
helminth infections as well as the development of responses to non-
parasite (bystander) antigens.
Methods
Ethical statement. Permission to conduct the study in the region was obtained from
the Provincial Medical Director and institutional and ethical approval was received
from the University of Zimbabwe’s Ethical Review Board and the Medical Research
Council of Zimbabwe respectively. Only compliant participants were recruited into
the study and they were free to drop out at any point during the study. At the
beginning of the study, participants and their parents/guardians (in case of children)
had the aims and procedures of the project explained fully in the local language,
Shona, and written consent and assent were obtained from participants and parents/
guardian before parasitology and blood samples were obtained. After collection of all
samples, all participants were offered anti-helminthic treatment with the
recommended dose of praziquantel (40 mg/kg of body weight).
Study population and parasitology. This study was performed in two villages,
Magaya and Chipinda, which are located in the Mashonaland East Province of
Zimbabwe (31u91’E; 17u63’S). The villages were selected because health surveys
regularly conducted in the region showed little or no infection with other helminths, a
low S. mansoni prevalence (,2%) and high S. haematobium prevalence as defined by
World Health Organisation on the criteria of having an infection prevalence greater
that 50%57. Villagers are subsistence farmers who have frequent contact with infective
water (as assessed by questionnaires) due to insufficient safe water and sanitation
facilities as is typical in rural Zimbabwe58. Drinking water is collected from open wells
while bathing and washing is conducted in perennial rivers surrounding the village.
This area has not been included in any schistosome control programmes and
therefore participants had not received anti-helminthic treatment for schistosomiasis
or other helminth infections meaning that their natural immune responses could be
studied in the absence of drug-altered schistosome responses11. Urine and stool
samples were collected on three consecutive days and analysed for S. haematobium
(urine filtration) and S. mansoni and intestinal helminths (Kato-Katz method)
respectively using standard procedures59,60.
Participants were screened for malaria infection (Plasmodium falciparum) by
microscopic examination of Giemsa stained blood smears and results confirmed
using a serological rapid test (Paracheck-PFH, Orchid Biomedical Systems, Goa,
India). HIV status was determined by immunochromatography
(DoubleCheckGoldTM HIV 1&2, Orgenics) with HIV positive samples subsequently
re-tested by a second rapid assay (Determine HIV 1/2 Ag/Ab Combo,
InvernessMedical) to confirm HIV status. For inclusion into the study participants
had to meet the following criteria (1) be life-long residents in this area (assessed by
questionnaires), (2) should not have received anti-helminthic treatment prior this
study, (3) should have provided at least two urine and two stool samples and (4)
should have tested negative for intestinal helminths as well as for S. mansoni (5) and
should have tested negative for HIV and Plasmodium infection and (6) should have
provided sufficient blood for subsequent analysis. The study area is mesoendemic for
Plasmodium infection61 and none of the participants were positive for malaria. To
relate immune responses to schistosome infections alone, all participants were
selected to be negative for HIV infection. These exclusion criteria did not bias the
population in terms of their schistosome epidemiology since the prevalence of HIV in
the whole study population was low at 8%.
The selected cohort comprised 105 participants (43 males, 62 females) with an age
range from 6–84 years (mean 16.2, details in Table 1). For some analyses (presented in
Figure 3) only a subset of this cohort could be analysed due to limited amount of
sample material. These analyses included 51 participants aged 6–17 years. After
collection of all samples, all participants were offered treatment with the
recommended dose of praziquantel (40 mg/kg of body weight).
To determine the effects of anti-helminthic treatment on the memory T cells,
participants were followed up after treatment. Six weeks following treatment, parti-
cipants provided urine, stool and blood samples as described above. This period of six
weeks was chosen to allow a high cure rate in terms of egg output62, but to avoid
establishment of patent re-infections. 36 treated participants were selected, who have
provided stool and urine samples (as described above) as well as sufficient blood
before and after treatment. In addition 14 individuals which either missed or refused
treatment (for religious reasons), but still were willing to be part of the study and
fulfilled listed the criteria formed the untreated control group. The age of the group
ranged from 7–17 years (mean 12.6 years). Participants who had missed treatment
were offered treatment with the standard dose of praziquantel after sample collection.
Blood collection and isolation of PBMC.Depending on participant age up to 25 ml
of venous blood was collected in heparinised tubes of which approximately 5 ml was
used for serological assays as well as microscopic detection of malaria parasites. The
remaining blood was used for the isolation of peripheral blood mononuclear cells
(PBMC) through density gradient centrifugation using LymphoprepTM (Axis-Shield,
Cambridgeshire, UK). These PBMC were subsequently enumerated, cryo-preserved
and stored in liquid nitrogen in Zimbabwe prior to shipping to Edinburgh in dry
shippers for assaying.
Phenotyping of PBMC. Thawing of cryo-preserved PBMC was performed by
rotating cryovials in a 37uC water bath until a small crystal was remaining in the cell
suspension. Cells were then slowly re-suspended in RPMI 1640 supplemented with
10% FCS, 2mML-glutamine and 100 U Penicillin/Streptomycin (all Lonza, Verviers,
Belgium). Cells were washed twice with the corresponding media, counted and
viability (mean 82.2 % 6 SEM 5 1.7%) assessed using trypan blue (Sigma-Aldrich,
Dorsert, UK). Cryo-preserved PBMCs have been previously used to assess changes
CD41 memory T cells and have been stored for much longer than in our study9. In
addition a comparison between fresh and cryo-preserved did not show difference in
naı¨ve or memory T cell proportions. Cells were washed with Dulbecco’s-PBS (Lonza)
and surface stained with the following antibodies: PerCP-conjugated anti-CD3
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(OKT-3), Alexa488-conjugated anti-CD4 (clone OKT-4), e450-conjugated anti-CD8
(RPA-T8), PE-conjugated anti-CD45RA (HI100), PE-Cy7-conjugated anti-CD62L
(DREG-56; all eBioscience, San Jose, USA), Pacific blue-conjugated anti-CD31
(WM59, Biolegend) and PE-Cy7-conjugated anti-HLA-DR (L243, BD Bioscience).
Stained cells were acquired on a FACSCantoIITM (BDBiosciences) and analyzed using
FlowJo software software (TreeStar, USA).
Cytokine and antibody assays. For the detection of cytokines PBMC (0.25x106) were
stimulated with 1 mg/ml phytohemagglutinin (PHA, Sigma) or with 10 mg/ml WWH
in X-vivoTM 15 medium (Lonzo, Verviers, Belgium) for 48 hours. Supernatants were
harvested and analysed for the cytokines IL-4, IL-5, IFN-c, using BD CBA array Flex
set bead technology following the manufacture’s instructions and a BD FACSarrayTM
Bioanalyzer was used to acquire data (BD Bioscience).
Enzyme-linked immunosorbent assays (ELISA) for adult-worm specific IgM, IgG4
and IgE were performed as described previously63,64.
Determination of Telomere length.CD45RO1CD41memory T cells were isolated
using magnetic beads following instructions of the manufacturer (Miltenyi Biotec,
Germany). CD41 T cells were isolated using a negative selection kit (Miltenyi Biotec,
130-091-155) followed by a positive selection using CD45RO microbeads (130-048-
001). Cells were washed, counted and genomic DNA was isolated using Qiamp DNA
blood mini kit (Qiagen, Germany). Quantitative PCR followed a previously reported
protocol65. For telomere amplification the following primers were used:
59-CGGTTTGTTTGGGTTTGGGTTTGGGTTTGGGTTTGGGTT-39 and
59-GGCTTGCCTTACCCT TACCCTTACCCTTACCCTTACCCT-39 both at a
concentration of 200 nM. The single copy gene 36b4 was used as control with
following primers: 59- CAGCAAGTGGGAAGGTGTAATCC-39 and
59- CCCATTCTATCATCAACGGGTACAA-39 both at 300 nM. SYBR-green PCR
was carried out using a PrecisionTM master mix kit (PrimerDesign). PCR was
conducted in duplicate and performed using a LightCyclerH 480 II (Roche). The
enzymewas activated at 95uC for 10min following 40 cycles of 10 sec at 95uC, 10 sec at
56uC for telomeres and 10 sec at 58uC for 36b4 followed by 60 sec at 60uC (telomere)
or 50 sec at 60uC (36b4). Ct values for telomeres were normalized using the single
copy gene 36b4.
Statistical analysis. All statistical tests were conducted using the software package
SPSS using methods described by Mutapi and Roddam66. P values were taken to be
significant at p , 0.05. In an initial analysis it was determined if there were overall
significant differences in the proportions of memory T cells between schistosome
infected and uninfected participants, a Mann-Whitney U test was conducted. To
further analyse which factors influence the proportions of T cell subsets or WWH-
specific antibody (dependent variable) transformed data (T cell proportions were
arcsine square root transformed as is standard for transforming proportions into
continuous data67, whereas antibody levels were square root transformed) were used
(to allow the use of parametric tests) in univariate analysis of variance using sex (male/
female), host age group (age groups 1–4) and infection status (uninfected 5 0 mean
egg count per 10 ml and infected . 0 mean egg count per 10 ml; all categorical) as
independent variables and contrast analysis between infected and uninfected
individuals was performed within each age group.
To determine the relationship between CD41 memory T cells and cytokine data
and between CD41HLA-DR1 T cells and CD41 memory T cells, a partial cor-
relation controlling for the effects of sex and age was used. For this analysis, cytokine
data were square root transformed whereas CD41 T cell subsets were arcsine square
root transformed.
To address the question of how anti-helminthic treatment affected memory T cell
proportions, a repeated measurement ANOVA was used.
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